SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004240
Filing Date
2021-11-12
Accepted
2021-11-12 07:34:44
Documents
65
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cyt-20210930.htm   iXBRL 10-Q 2055088
2 EX-31.1 cyt-ex31_1.htm EX-31.1 18910
3 EX-31.2 cyt-ex31_2.htm EX-31.2 18886
4 EX-32.1 cyt-ex32_1.htm EX-32.1 10914
5 EX-32.2 cyt-ex32_2.htm EX-32.2 10900
  Complete submission text file 0000950170-21-004240.txt   6422165

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cyt-20210930.xsd EX-101.SCH 42789
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cyt-20210930_lab.xml EX-101.LAB 338647
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cyt-20210930_def.xml EX-101.DEF 149650
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cyt-20210930_cal.xml EX-101.CAL 32224
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cyt-20210930_pre.xml EX-101.PRE 252975
11 EXTRACTED XBRL INSTANCE DOCUMENT cyt-20210930_htm.xml XML 1030868
Mailing Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Filer) CIK: 0001662244 (see all company filings)

IRS No.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40499 | Film No.: 211399603
SIC: 2834 Pharmaceutical Preparations